Tradestie Institutional Equity Comparison Engine

KTTA vs OLB โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KTTA Overall Edge

KTTA Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pasithea Therapeutics Corp. Common Stock (KTTA) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, KTTA trades at N/M Forward P/E with 0.0% operating margin (+1498.1% YoY revenue) versus OLB at N/M Forward P/E and -73.3% operating margin (-43.6% YoY). In options structure, KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OLB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
KTTA N/M vs OLB N/M Fwd P/E
Growth & Margin Winner KTTA
Op Margin 0.0% vs -73.3% ยท YoY +1498.1% vs -43.6%
Momentum & Technical Winner KTTA
1Y +0.6% vs -87.4% ยท 52W Pos 11% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0
OLB NASDAQ
The OLB Group, Inc. Common Stock
Services-Business Services, Nec
$0.12
-4.33% 1D
Market Cap $3.8M
1M Return -63.26%
1Y Return -87.36%
Forward P/E N/M
Unified AI Score
48.6 / 100 HOLD
Tech 48.0 Fund 46.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KTTA +0.59% OLB -87.36% Spread: +87.95 pp (KTTA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period KTTA Revenue OLB Revenue KTTA Op. Margin OLB Op. Margin Margin Edge
FY2018 N/A $10M N/A 5.9% OLB
FY2019 N/A $10M N/A -2.6% OLB
FY2020 N/A $10M N/A -7.5% OLB
FY2021 $0M $20M -29925.7% -28.5% OLB
FY2022 $0M $30M -2587.3% -26.9% OLB
FY2023 N/A $30M N/A -76.8% OLB
FY2024 N/A $10M N/A -90.9% OLB
FY2025 N/A $10M N/A -59.5% OLB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KTTA (5) vs OLB (3)
Institutional Metric KTTA OLB Criterion Row Winner
Market Capitalization Scale $17.7M $3.8M Larger Scale KTTA
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +1498.1% -43.6% Higher Growth KTTA
Operating Margin (TTM) Profitability 0.0% -73.3% Higher Margin KTTA
Net Profit Margin Profitability 0.0% -68.2% Higher Margin KTTA
Return on Equity (ROE) Capital Efficiency -88.8% -70.8% Higher ROE OLB
52-Week Range Position Momentum 11% ($0โ€“$2) 0% ($0โ€“$2) Stronger Trend KTTA
Beta / 30D Volatility Risk Regime 0.68ฮฒ ยท 185% Vol 1.80ฮฒ ยท 120% Vol Lower Realized Risk OLB
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 48.6 / 100 (HOLD) Higher Composite OLB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KTTA vs OLB Buy Guide
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OLB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OLB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KTTA nor OLB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.